Oragenics Free Cash Flow (FCF) History (OGEN)

Oragenics reported −$15.4M in free cash flow for fiscal 2022, a decrease of $1.8M from the previous fiscal year, with a free cash flow margin of −11675.70%.

View full Oragenics company overview

Oragenics free cash flow by year

Oragenics annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20222022-12-31−$15.4M−$1.8M−11675.70%
20212021-12-31−$13.5M−$476,031−15535.76%
20192019-12-31−$13.0M−$3.8M
20182018-12-31−$9.2M−$2.1M
20162016-12-31−$7.1M−$1.8M
20152015-12-31−$5.3M$377,802
20142014-12-31−$5.7M$1.1M−603.22%
20132013-12-31−$6.8M−$1.6M−657.15%
20122012-12-31−$5.2M$1.3M−392.18%
20102010-12-31−$6.5M−499.39%

Oragenics free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −$5.3M to −$15.4M, a net decrease of $10.1M. Oragenics's latest reported quarter, Q4 2022, generated −$2.4M in free cash flow, an increase of $941,432 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Oragenics filings at SEC.gov ↗